Selected Issues Associated with the Risk Assessment Process for ...

FIFRA SCIENTIFIC ADVISORY PANEL (SAP) OPEN MEETING

SELECTED ISSUES ASSOCIATED WITH THE RISK ASSESSMENT PROCESS FOR PESTICIDES WITH PERSISTENT, BIOACCUMULATIVE AND TOXIC CHARACTERISTICS

U.S. ENVIRONMENTAL PROTECTION AGENCY CONFERENCE CENTER- LOBBY LEVEL

ONE POTOMAC YARD (SOUTH BUILDING) 2777 South Crystal Drive Arlington, Virginia 22202 OCTOBER 28, 2008 8:42 A.M.

EPA MEETING 10/28/08 CCR#16076-1

2

1

FIFRA SCIENTIFIC ADVISORY PANEL

2

MEETING

3

October 28, 2008

4

MS. CHRISTIAN: Good morning. I am Myrta

5 Christian and I will be serving as the designated

6 federal official to the FIFRA Scientific Advisory

7 Panel. I want to thank Dr. Heeringa for agreeing to

8 serve as chair of the FIFRA Scientific Advisory Panel

9 for this meeting. I also want to thank both the

10 members of the panel and the public for attending this

11 important meeting of the FIFRA SAP to consider selected

12 issues associated with risk assessment process for

13 pesticides with persistent, bioaccumulative, and toxic

14 characteristics.

15

We appreciate the time and effort of the

16 panel members in preparing for this meeting and taking

17 time out of their busy schedules. The FIFRA SAP is a

18 federal advisory committee that provides independent,

19 scientific counsel and advice to the agency on

20 pesticides and pesticide related issues regarding the

21 proposed federal action on human health and

22 environment. The FIFRA SAP only provides advice and

23 recommendations to EPA. Decision making and

24 implementation authority remains with the agency. As

25 the DFO for this meeting, I serve as the liaison

EPA MEETING 10/28/08 CCR#16076-1

3

1 between the panel and the agency.

2

I am also responsible for issuing

3 permission of the federal advisory committee as needed.

4 As the designated federal official for this meeting, a

5 critical responsibility is to work with the appropriate

6 agency officials to ensure that all appropriate ethics

7 regulations are satisfied. In that capacity, panel

8 members are briefed with provisions of federal conflict

9 of interest laws.

10

In addition, each participant has signed

11 a standard government financial disclosure report. I,

12 along with our deputy ethics officer for the office of

13 pesticides and toxic substances and consultation with

14 office of the general counsel have reviewed these forms

15 to ensure all ethics requirements are met.

16

For members of the public requesting

17 time to make a public comment, please limit your

18 comments to five minutes unless prior arrangements have

19 been made. For those who have not pre-registered,

20 please notify either myself or another member of the

21 SAP staff if you're interest in making a comment.

22

For presenters, panel members and public

23 commentors, please identify yourself and speak into the

24 microphone provided, since this meeting has been

25 recorded. There is a public docket for this meeting.

EPA MEETING 10/28/08 CCR#16076-1

4

1 All background material, questions posed to the panel

2 by the agency and other documents related to this

3 meeting are available in the docket. Overheads will be

4 available in a few days.

5

Background documents are also available

6 on the EPA website. The agenda lists contact

7 information for such documents. At the conclusion of

8 the meeting, the SAP will prepare a report as a

9 response to questions posed by the agency, background

10 material, presentations and public comment. The report

11 serves as meeting minutes.

12

We anticipate the meeting minutes will

13 be completed in the first 90 days. Again, I wish to

14 thank the panel for their participation and I'm looking

15 forward to both a challenging and interesting

16 discussion over the next few days.

17

Finally, I just want to let you know

18 that there is a big meeting tomorrow morning at 8:30 in

19 this building. Therefore, the security line is

20 expected to be longer than normal. Please plan

21 accordingly. At this point, I would like to introduce

22 Dr. Steven Heeringa, the Chair for the FIFRA Scientific

23 Advisory Panel.

24

DR. HEERINGA: Thank you very much

25 Myrta. I'd like to reiterate her thanks to the members

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download